Speaker Profile
Ph.D., Vice President, Research & Development, Castle Biosciences
Biography
Dr. Rebecca Critchley-Thorne joined Castle Biosciences in December 2021 as Vice President, RD, Spatialomics and GI, as part of the acquisition of Cernostics Inc., where she was Co-Founder and Chief Scientific Officer. She led the development of the Tissue Cypher computational pathology platform as well as the Tissue Cypher Barretts Esophagus test and its supporting clinical studies. She currently oversees RD for Castles commercially available tests and pipeline activities. She completed training as a postdoctoral fellow at Stanford University, where she focused on highly multiplexed analysis of biomarkers to understand mechanisms of immune dysfunction in various cancer types. She completed doctoral work in cancer immunotherapy at Imperial College and Cancer Research UK in London, UK, and earned a B. S. (Hons) degree in Pharmacology from the University of Sheffield, UK. Dr. Critchley-Thorne is the author of many medical and scientific publications, a principal investigator on NIH-funded research studies, and an inventor on several of Castle's patents.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Serge Saxonov, 10x Genomics
PMWC Award Ceremony
• Sarah Teichmann, Wellcome Sanger Institute (Luminary)
• Aviv Regev, Genentech (Pioneer)
Featured Speakers
• Sarah Teichmann, Wellcome Sanger Institute
• Aviv Regev, Genentech
• Eric Lander, Broad Institute
• Gad Getz, Broad Institute
• Emma Lundberg, Stanford
• Garry Nolan, Stanford
• Nikhil Wagle, Genentech
• Satish Viswanath, Emory
• Alex Shalek, MIT / Broad Institute
• Christina Curtis, Stanford
• Fei Chen, Broad Institute
• Andy Beck, PathAI
• Kevin Wei, Harvard
• Rebecca Critchley-Thorne, Castle Biosciences
• Dan Rozelle, Rancho BioSciences
• Maximilian Strauss, OmicVision
The Next Map of Biology
From the Human Genome to the Human Cell Atlas in the AI era.
Spatial Biology in Practice
From tissue architecture to decisions that change the answer.
Spatial Proteomics
Cell states, therapeutic targets, and what can be measured in context.
Spatial Pathology from Discovery to Clinical Biomarker
Turning a beautiful image into a validated test.
AI for Spatial Biology
Foundation models, digital pathology, and tissue-scale interpretation.
Scaling Spatial Biology to Clinical Translation
From discovery platform to reproducible clinical evidence.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
